We are live on ! Find out more
BGIM

Boussard & Gavaudan Investment Management Portfolio holdings

AUM $1.06B
1-Year Est. Return 4.58%
This Fund
S&P 500
This Quarter Est. Return
-3.43%
1 Year Est. Return
+4.58%
3 Year Est. Return
+25.82%
5 Year Est. Return
+33.18%
10 Year Est. Return
+356.42%
AUM
$1.18M
AUM Growth
-$1.05B
Cap. Flow
-$403M
Cap. Flow %
-34,025.24%
Top 10 Hldgs %
51.44%
Holding
164
New
55
Increased
4
Reduced
8
Closed
25
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENJY
51
DELISTED
Enjoy Technology, Inc. Common Stock
ENJY
$912 0.08%
91,269
+11,770
+15% +$117K
CVII
52
DELISTED
Churchill Capital Corp VII Class A Common Stock
CVII
$760 0.06%
78,191
SOND
53
DELISTED
Sonder
SOND
$618 0.05%
3,125
RGTI icon
54
Rigetti Computing
RGTI
$6.15B
$598 0.05%
61,550
BKSY.WS
55
DELISTED
BlackSky Technology Inc Warrants
BKSY.WS
$587 0.05%
+371,479
New +$621K
ALIT.WS
56
DELISTED
Alight Inc Warrants
ALIT.WS
$574 0.05%
+188,100
New +$469K
PRPC
57
DELISTED
CC Neuberger Principal Holdings III
PRPC
$561 0.05%
57,400
BSN.WS
58
DELISTED
Broadstone Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share
BSN.WS
$496 0.04%
458,850
BABA icon
59
CALL
Alibaba
BABA
$300B
$491 0.04%
+1,743
New +$317K
UHG
60
DELISTED
United Homes Group
UHG
$486 0.04%
50,000
ALUS.WS
61
DELISTED
Alussa Energy Acquisition Corp Warrants
ALUS.WS
$474 0.04%
160,290
-114,710
-42% -$237K
DCRCW
62
DELISTED
Decarbonization Plus Acquisition Corporation III Warrant
DCRCW
$420 0.04%
200,000
AVAN.WS
63
DELISTED
Avanti Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
AVAN.WS
$327 0.03%
500,000
AAL icon
64
PUT
American Airlines Group
AAL
$9.88B
$323 0.03%
+5,000
New +$101K
JOBY.WS
65
DELISTED
Joby Aviation Warrants
JOBY.WS
$281 0.02%
+125,000
New +$268K
ORGNW
66
DELISTED
Origin Materials Inc Warrants
ORGNW
$262 0.02%
166,667
FTVI
67
DELISTED
FinTech Acquisition Corp. VI Class A Common Stock
FTVI
$249 0.02%
+25,000
New +$244K
FTAA
68
DELISTED
FTAC Athena Acquisition Corp. Class A Ordinary Share
FTAA
$247 0.02%
25,000
SRTAW
69
DELISTED
Strata Critical Medical Inc Warrants
SRTAW
$221 0.02%
76,852
-23,148
-23% -$48.4K
SYM icon
70
Symbotic
SYM
$5.35B
$197 0.02%
20,000
SVFB
71
DELISTED
SVF Investment Corp. 2 Class A Ordinary Shares
SVFB
$196 0.02%
20,000
TSIB
72
DELISTED
Tishman Speyer Innovation Corp. II Class A common stock
TSIB
$196 0.02%
20,000
TREB.WS
73
DELISTED
Trebia Acquisition Corp. Warrants, each whole warrant exercisable for one Class A Ordinary Share at
TREB.WS
$169 0.01%
116,666
IPOF.WS
74
DELISTED
Social Capital Hedosophia Holdings Corp. VI Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
IPOF.WS
$140 0.01%
75,000
PRPB.WS
75
DELISTED
CC Neuberger Principal Holdings II Redeemable warrants, each whole warrant exercisable for one Class
PRPB.WS
$126 0.01%
125,000

Similar funds

Boussard & Gavaudan Investment Management's Q3 2021 Portfolio in Review

As of Q3 2021, Boussard & Gavaudan Investment Management held 164 positions worth $1.18M, down 100% from $1.05B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Boussard & Gavaudan Investment Management withdrew a net $403M in Q3 2021, closing 25 positions and reducing 8 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $115M position sold in full.

By sector, the portfolio is most concentrated in Financials at 12% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Boussard & Gavaudan Investment Management opened a new position in BGC Group worth $27.3K.

  • Boussard & Gavaudan Investment Management's largest Q3 2021 buy was BGC Group: 5,236,279 shares worth $27.3K.
  • Boussard & Gavaudan Investment Management added most to Octave Specialty Group in Q3 2021, an estimated $3.11M increase.
  • Boussard & Gavaudan Investment Management's biggest Q3 2021 reduction was Alibaba, cutting an estimated $72.9M.
  • Boussard & Gavaudan Investment Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $115M.
  • Boussard & Gavaudan Investment Management's ten largest holdings make up 51% of its $1.18M portfolio in Q3 2021.
  • Boussard & Gavaudan Investment Management opened 55 new positions and closed 25 in Q3 2021.
  • Boussard & Gavaudan Investment Management's portfolio value fell 100% quarter-over-quarter to $1.18M.

Based on Boussard & Gavaudan Investment Management's 13F filing for Q3 2021, filed 8 Nov 2021.